TY - JOUR
T1 - Knowledge, practices and risk awareness regarding non-prescription weight loss supplements among university students in UAE
AU - Jairoun, Ammar Abdulrahman
AU - Al-Hemyari, Sabaa Saleh
AU - Saeed, Balsam Qubais
AU - Shahwan, Moyad
AU - Al-Ani, Mena
AU - Khattab, Mohammed Husham
AU - Godman, Brian
AU - AL-Tamimi, Saleh Karamah
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - Aim: To assess knowledge and risk awareness about weight loss supplements and their possible adverse consequences, and to investigate significant factors impacting such knowledge and risk awareness. Subject and methods: A descriptive analytical cross-sectional community-based study was performed among students and teaching staff at Ajman University (AU). A self-administered survey was sent to respondents’ emails via a web-based electronic link. The questionnaire included demographic data, respondents’ knowledge and risk awareness about the use of the weight loss supplements they were taking and their ingredients, and adverse events after the use of any weight loss supplements. Results: One thousand participants completed the questionnaire. Most participants had good risk awareness about weight loss supplements. A total of 391 (39.1%; 95% CI: 30.7–48) participants used weight loss supplement products, and among them, 126 (32.2%; 95% CI: 22.4–36) experienced related side effects. The most common complaints were gastrointestinal symptoms (34.9%); warmth or redness of the face, neck, or chest (25.4%); and headaches (17.5%). A multivariate analysis showed that better risk awareness scores regarding weight loss supplement use were significantly associated with educational level, employment status, and participant gender. Conclusion: The current study revealed some misconceptions about the safety of slimming dietary supplements (SDS). Consequently, awareness should be raised regarding SDS use, and regulatory action should be taken to prevent their inappropriate or excessive SDS use.
AB - Aim: To assess knowledge and risk awareness about weight loss supplements and their possible adverse consequences, and to investigate significant factors impacting such knowledge and risk awareness. Subject and methods: A descriptive analytical cross-sectional community-based study was performed among students and teaching staff at Ajman University (AU). A self-administered survey was sent to respondents’ emails via a web-based electronic link. The questionnaire included demographic data, respondents’ knowledge and risk awareness about the use of the weight loss supplements they were taking and their ingredients, and adverse events after the use of any weight loss supplements. Results: One thousand participants completed the questionnaire. Most participants had good risk awareness about weight loss supplements. A total of 391 (39.1%; 95% CI: 30.7–48) participants used weight loss supplement products, and among them, 126 (32.2%; 95% CI: 22.4–36) experienced related side effects. The most common complaints were gastrointestinal symptoms (34.9%); warmth or redness of the face, neck, or chest (25.4%); and headaches (17.5%). A multivariate analysis showed that better risk awareness scores regarding weight loss supplement use were significantly associated with educational level, employment status, and participant gender. Conclusion: The current study revealed some misconceptions about the safety of slimming dietary supplements (SDS). Consequently, awareness should be raised regarding SDS use, and regulatory action should be taken to prevent their inappropriate or excessive SDS use.
KW - Knowledge
KW - Risk awareness
KW - Side effects
KW - Slimming dietary supplements
KW - UAE
UR - http://www.scopus.com/inward/record.url?scp=85167811431&partnerID=8YFLogxK
U2 - 10.1007/s10389-023-02046-5
DO - 10.1007/s10389-023-02046-5
M3 - Article
AN - SCOPUS:85167811431
SN - 2198-1833
JO - Zeitschrift fur Gesundheitswissenschaften
JF - Zeitschrift fur Gesundheitswissenschaften
ER -